Deutsche Bank AG Purchases 537 Shares of Inspire Medical Systems, Inc. $INSP

Deutsche Bank AG increased its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 8.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,821 shares of the company’s stock after buying an additional 537 shares during the period. Deutsche Bank AG’s holdings in Inspire Medical Systems were worth $1,086,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Mariner LLC increased its stake in shares of Inspire Medical Systems by 1.6% during the 4th quarter. Mariner LLC now owns 4,837 shares of the company’s stock worth $897,000 after purchasing an additional 77 shares during the last quarter. First Trust Advisors LP bought a new position in Inspire Medical Systems during the fourth quarter worth about $18,837,000. Dimensional Fund Advisors LP increased its position in Inspire Medical Systems by 98.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 232,333 shares of the company’s stock worth $43,069,000 after buying an additional 115,024 shares during the last quarter. MML Investors Services LLC increased its position in Inspire Medical Systems by 0.9% during the fourth quarter. MML Investors Services LLC now owns 7,941 shares of the company’s stock worth $1,472,000 after buying an additional 67 shares during the last quarter. Finally, State of Tennessee Department of Treasury raised its stake in Inspire Medical Systems by 49.1% in the fourth quarter. State of Tennessee Department of Treasury now owns 14,229 shares of the company’s stock valued at $2,638,000 after buying an additional 4,684 shares during the period. Institutional investors and hedge funds own 94.91% of the company’s stock.

Wall Street Analysts Forecast Growth

INSP has been the subject of several research analyst reports. Stifel Nicolaus set a $140.00 target price on Inspire Medical Systems and gave the stock a “hold” rating in a research note on Tuesday, August 5th. KeyCorp cut shares of Inspire Medical Systems from an “overweight” rating to a “sector weight” rating in a research report on Tuesday, August 5th. Wells Fargo & Company dropped their price objective on shares of Inspire Medical Systems from $174.00 to $101.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 5th. Robert W. Baird lifted their target price on shares of Inspire Medical Systems from $230.00 to $236.00 and gave the stock an “outperform” rating in a report on Tuesday, May 6th. Finally, UBS Group set a $230.00 price target on shares of Inspire Medical Systems and gave the company a “buy” rating in a research note on Tuesday, August 5th. Seven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Moderate Buy” and a consensus target price of $165.62.

Inspire Medical Systems Stock Performance

Shares of Inspire Medical Systems stock opened at $95.7980 on Monday. The firm has a 50-day moving average of $117.55 and a 200-day moving average of $144.21. Inspire Medical Systems, Inc. has a 52-week low of $73.92 and a 52-week high of $225.00. The stock has a market cap of $2.83 billion, a PE ratio of 55.37, a PEG ratio of 2.99 and a beta of 1.22.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Monday, August 4th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.23. The business had revenue of $217.09 million for the quarter, compared to analyst estimates of $214.50 million. Inspire Medical Systems had a net margin of 6.17% and a return on equity of 10.38%. Inspire Medical Systems’s revenue for the quarter was up 10.8% compared to the same quarter last year. During the same period last year, the firm earned $0.32 earnings per share. Inspire Medical Systems has set its FY 2025 guidance at 0.400-0.500 EPS. Equities research analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Inspire Medical Systems declared that its board has approved a share buyback program on Monday, August 11th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 8.6% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board of directors believes its shares are undervalued.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.